Article Information
History
- February 2, 2021.
Article Versions
- Version 1 (January 20, 2021 - 11:24).
- You are currently viewing Version 2 of this article (February 2, 2021 - 06:43).
- Version 3 (February 3, 2021 - 15:18).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dami A. Collier1,2,3,*,
- Anna De Marco4,*,
- Isabella A.T.M. Ferreira*,1,2,
- Bo Meng1,2,*,
- Rawlings Datir*,1,2,3,
- Alexandra C. Walls5,
- Steven A. Kemp S1,2,3,
- Jessica Bassi4,
- Dora Pinto4,
- Chiara Silacci Fregni4,
- Siro Bianchi4,
- M. Alejandra Tortorici5,
- John Bowen5,
- Katja Culap4,
- Stefano Jaconi4,
- Elisabetta Cameroni4,
- Gyorgy Snell6,
- Matteo S. Pizzuto4,
- Alessandra Franzetti Pellanda7,
- Christian Garzoni7,
- Agostino Riva8,
- The CITIID-NIHR BioResource COVID-19 Collaboration9,
- Anne Elmer10,
- Nathalie Kingston10,
- Barbara Graves10,
- Laura E McCoy3,
- Kenneth GC Smith1,2,
- John R. Bradley2,10,
- J James Thaventhiran2,
- L Lourdes Ceron-Gutierrez11,
- Gabriela Barcenas-Morales11,12,
- Herbert W. Virgin6,
- Antonio Lanzavecchia4,
- Luca Piccoli4,
- Rainer Doffinger11,
- Mark Wills2,
- David Veesler5,
- Davide Corti4,*,† and
- Ravindra K. Gupta1,2,13,*,†
- 1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
- 2Department of Medicine, University of Cambridge, Cambridge, UK
- 3Division of Infection and Immunity, University College London, London, UK
- 4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
- 5Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
- 6Vir Biotechnology, San Francisco, CA 94158, USA
- 7Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland
- 8Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, 20157 Milan, Italy
- 9The CITIID-NIHR BioResource COVID-19 Collaboration, see appendix 1 for author list
- 10NIHR Cambridge Clinical Research Facility, Cambridge, UK
- 11Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, UK
- 12Laboratorio de Inmunologia, S-Cuautitlán, UNAM, Mexico
- 13Africa Health Research Institute, Durban, South Africa
- ↵†Correspondence:
dcorti{at}vir.bio, rkg20{at}cam.ac.uk
↵* Equal contribution
Posted February 02, 2021.
